Immunomodulatory capacity of human mesenchymal stem cells isolated from adipose tissue, dental pulp, peripheral blood and umbilical cord Wharton's jelly

Central-European Journal of Immunology

Volumn 38, Issue 4, 2013, Pages 421-429

  Trivanović, Drenka ^a   Mojsilović, Slavko ^a   Ilić, Vesna ^a   Krst Ić, Jelena ^a   Jauković, Aleksandra ^a   Okić Dordević, Ivana ^a   Santibanez, Juan Francisco ^a   Jovčić, Gordana ^a   Bugarski, Diana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Immunomodulation; Mesenchymal stem cells; PBMCs; Proinflammatory

Indexed keywords

ALLOANTIGEN; CYCLOOXYGENASE 2; GAMMA INTERFERON; HLA ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 6; PHYTOHEMAGGLUTININ; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ARTICLE; BLOOD; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; DECIDUOUS TOOTH; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; MIXED LYMPHOCYTE REACTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; TOOTH PULP; UMBILICAL CORD; WHARTON JELLY;

EID: 84892148234     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: 10.5114/ceji.2013.39756     Document Type: Article

References (38)

1. Augello A, Kurth TB, De Bari C (2010): Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. Eur Cell Mater 20: 121133.
2. Hass R, Kasper C, Böhm S, Jacobs R (2011): Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 9: 12.
3. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP (1968): Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6: 230-247.
4. Hong HS, Kim YH, Son Y (2012): Perspectives on mesenchymal stem cells: tissue repair, immune modulation, and tumor homing. Arch Pharm Res 35: 201-211.
5. Ghannam S, Bouffi C, Djouad F, et al. (2010): Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res Ther 15; 1: 2.
6. English K. Mechanisms of mesenchymal stromal cell immunomodulation. (2013): Immunol Cell Biol 91: 19-26.
7. Ryan JM, Barry F, Murphy JM, Mahon BP (2007): Interferon- gamma does not break, but promotes the immunosuppres sive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 149: 353-363.
8. DelaRosa O, Lombardo E, Beraza A, et al. (2009): Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells. Tissue Eng Part A 15: 2795-2806.
9. Crop MJ, Baan CC, Korevaar SS, Ijzermans JN, et al. (2010): Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells. Clin Exp Immunol 162: 474-486.
10. Nikolić N, Krstić A, Trivanović D, et al. (2011): Mesenchymal stem cell properties of dental pulp cells from deciduous teeth. Arch Biol Sci Belgrade 63: 933-942.
11. Trivanović D, Kocić J, Mojsilović S, et al. (2013): Mesenchymal stem cells isolated from peripheral blood and umbilical cord Wharton?s jelly. Srpski arhiv za celokupno lekarstvo 141: 178-186.
12. Le Blanc K, Samuelsson H, Lönnies L, et al. (2007): Generation of immunosuppressive mesenchymal stem cells in allogeneic human serum. Transplantation 84: 1055-1059.
13. Samuelsson H, Ringdén O, Lönnies H, Le Blanc K (2009): Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells. Cytotherapy 11: 129-136.
14. Roobrouck VD, Clavel C, Jacobs SA, et al. (2011): Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions. Stem Cells 29: 871-882.
15. Ivanova-Todorova E, Bochev I, Dimitrov R, et al. (2012): Conditioned medium from adipose tissue-derived mesenchymal stem cells induces CD4+FOXP3+ cells and increases IL- 10 secretion. J Biomed Biotechnol doi: 10.1155/2012/295167.
16. Pearce NW, Sedgwick JD (1997): Enzyme immunoassays for detection of cell surfaced molecules, single cell products, and proliferation. In: Johnstone JP, Turner MW, editors. Immunochemistry 1, A practical approach, Oxford University Press: Oxford, New York, pp. 215-37.
17. Puissant B, Barreau C, Bourin P, et al. (2005): Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 129: 118-129.
18. Wolbank S, Peterbauer A, Fahrner M, et al. (2007): Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 13: 1173-1183.
19. Najar M, Raicevic G, Boufker HI, et al. (2010): Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton?s Jelly and bone marrow sources: Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells. Exp Cell Res 316: 3109-3123.
20. Yáez R, Oviedo A, Aldea M, et al. (2010): Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells. Exp Cell Res 316: 3109-3123.
21. Rasmusson I, Le Blanc K, Sundberg B, Ringdén O (2007): Mesenchymal stem cells stimulate antibody secretion in human B cells. Scand J Immunol 65: 336-343.
22. Najar M, Rouas R, Raicevic G, et al. (2009): Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6. Cytotherapy 11: 570-583.
23. Potian JA, Aviv H, Ponzio NM, et al. (2003): Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol 17: 3426-3434.
24. Fibbe WE, Nauta AJ, Roelofs H (2007): Modulation of immune responses by mesenchymal stem cells. Ann N Y Acad Sci 1106: 272-278.
25. Dominici M, Le Blanc K, Mueller I, et al. (2006): Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
26. Najar M, Raicevic G, Fayyad-Kazan H, et al. (2012): Immune- realeted antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: the expression and impact of inflammatory priming. Stem Cell Rev 8: 1188-1198.
27. Crop MJ, Baan CC, Korevaar SS, et al. (2010): Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation. Stem Cells Dev 19: 1843-1853.
28. Nasef A, Chapel A, Mazurier C, et al. (2007): Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. Gene Expr 13: 217-226.
29. Wang M, Yang Y, Yang D, et al. (2009): The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 126: 220-32.
30. Benvenuto F, Ferrari S, Gerdoni E, et al. (2007): Human mesenchymal stem cells promote survival of T cells in a quiescent state. Stem Cells 25: 1753-1760.
31. Lee JM, Jung J, Lee HJ, et al. (2012): Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells. Int Immunopharmacol 13: 219-224.
32. Prasanna SJ, Gopalakrishnan D, Shankar SR, Vasandan AB (2010): Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PloS One doi: 10.1371/journal.pone.0009016.
33. Hemeda H, Jakob M, Ludwig AK, et al. (2010): Interferon- gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells. Stem Cells Dev 19: 693-706.
34. Yoo KH, Jang IK, Lee MW, et al. (2009): Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol 259: 150-156.
35. Kaltz N, Ringe J, Holzwarth C, et al. (2010): Novel markers of mesenchymal stem cells defined by genome-wide gene expression analysis of stromal cells from different sources. Exp Cell Res 316: 2609-2617.
36. Jacobs SA, Roobrouck VD, Verfaillie CM, Van Gool SW (2013): Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells. Immunol Cell Biol 91: 32-39.
37. Yang ZX, Han ZB, Ji YR, et al. (2013): CD106 identifies a subpopulation of mesenchymal stem cells with unique immunomodulatory properties. PLoS One doi: 10.1371/journal. pone.0059354.
38. Lazzarotto-Silva C, Binato R, Rocher BD, et al. (2009): Similar proteomic profiles of human mesenchymal stromal cells from different donors. Cytotherapy 11: 268-277.